Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Motor Activity 2Breast Neoplasms 2Fatigue 1Arthralgia 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × methyl hydroxyethyl cellulose × Breast × Clear all
NCT02682836 2022-01-06

Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Fatigue, Motor Activity

NCT01900418 2016-08-08

Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy

University of North Carolina, Chapel Hill

Phase NA Completed
78 enrolled
Breast

Breast Neoplasms, Motor Activity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡